Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate.

Graczyk-Jarzynka A, Goral A, Muchowicz A, Zagozdzon R, Winiarska M, Bajor M, Trzeciecka A, Fidyt K, Krupka JA, Cyran J, Szczygiel K, Efremov DG, Gobessi S, Jagielski A, Siudakowska K, Bobrowicz M, Klopotowska M, Barankiewicz J, Malenda A, Lech-Maranda E, Miazek-Zapala N, Skarzynski PH, Domagala A, Golab J, Firczuk M.

Redox Biol. 2019 Feb;21:101062. doi: 10.1016/j.redox.2018.11.020. Epub 2018 Nov 29.

2.

Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy.

Urbanowicz A, Zagożdżon R, Ciszek M.

Arch Immunol Ther Exp (Warsz). 2019 Apr;67(2):79-88. doi: 10.1007/s00005-018-0532-8. Epub 2018 Nov 15. Review.

3.

Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.

Eustace AJ, Conlon NT, McDermott MSJ, Browne BC, O'Leary P, Holmes FA, Espina V, Liotta LA, O'Shaughnessy J, Gallagher C, O'Driscoll L, Rani S, Madden SF, O'Brien NA, Ginther C, Slamon D, Walsh N, Gallagher WM, Zagozdzon R, Watson WR, O'Donovan N, Crown J.

BMC Cancer. 2018 Oct 11;18(1):965. doi: 10.1186/s12885-018-4852-1.

4.

Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.

Bajor M, Zych AO, Graczyk-Jarzynka A, Muchowicz A, Firczuk M, Trzeciak L, Gaj P, Domagala A, Siernicka M, Zagozdzon A, Siedlecki P, Kniotek M, O'Leary PC, Golab J, Zagozdzon R.

Br J Cancer. 2018 Oct;119(7):873-884. doi: 10.1038/s41416-018-0263-y. Epub 2018 Oct 5.

PMID:
30287919
5.

Intraurethral co-transplantation of bone marrow mesenchymal stem cells and muscle-derived cells improves the urethral closure.

Burdzinska A, Dybowski B, Zarychta-Wiśniewska W, Kulesza A, Butrym M, Zagozdzon R, Graczyk-Jarzynka A, Radziszewski P, Gajewski Z, Paczek L.

Stem Cell Res Ther. 2018 Sep 21;9(1):239. doi: 10.1186/s13287-018-0990-2.

6.

Outcomes of Prolonged Treatment With Intravenous Immunoglobulin Infusions for Acute Antibody-mediated Rejection in Kidney Transplant Recipients.

Bujnowska A, Michon M, Konopelski P, Hryniewiecka E, Jalbrzykowska A, Perkowska-Ptasinska A, Cieciura T, Zagozdzon R, Paczek L, Ciszek M.

Transplant Proc. 2018 Jul - Aug;50(6):1720-1725. doi: 10.1016/j.transproceed.2018.02.110. Epub 2018 Mar 13.

PMID:
29961551
7.

Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.

Domagala A, Stachura J, Gabrysiak M, Muchowicz A, Zagozdzon R, Golab J, Firczuk M.

BMC Cancer. 2018 Feb 20;18(1):210. doi: 10.1186/s12885-018-4126-y.

8.

Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors.

Oei VYS, Siernicka M, Graczyk-Jarzynka A, Hoel HJ, Yang W, Palacios D, Almåsbak H, Bajor M, Clement D, Brandt L, Önfelt B, Goodridge J, Winiarska M, Zagozdzon R, Olweus J, Kyte JA, Malmberg KJ.

Cancer Immunol Res. 2018 Apr;6(4):467-480. doi: 10.1158/2326-6066.CIR-17-0207. Epub 2018 Feb 19.

9.

Application of Genome Editing Techniques in Immunology.

Zych AO, Bajor M, Zagozdzon R.

Arch Immunol Ther Exp (Warsz). 2018 Aug;66(4):289-298. doi: 10.1007/s00005-018-0504-z. Epub 2018 Jan 17. Review.

10.

Oxidative Stress in Kidney Diseases: The Cause or the Consequence?

Krata N, Zagożdżon R, Foroncewicz B, Mucha K.

Arch Immunol Ther Exp (Warsz). 2018 Jun;66(3):211-220. doi: 10.1007/s00005-017-0496-0. Epub 2017 Dec 6. Review.

11.

In vivo imaging system for explants analysis-A new approach for assessment of cell transplantation effects in large animal models.

Zarychta-Wiśniewska W, Burdzinska A, Zagozdzon R, Dybowski B, Butrym M, Gajewski Z, Paczek L.

PLoS One. 2017 Sep 20;12(9):e0184588. doi: 10.1371/journal.pone.0184588. eCollection 2017.

12.

New insights into redox homeostasis as a therapeutic target in B-cell malignancies.

Graczyk-Jarzynka A, Zagozdzon R, Muchowicz A, Siernicka M, Juszczynski P, Firczuk M.

Curr Opin Hematol. 2017 Jul;24(4):393-401. doi: 10.1097/MOH.0000000000000351. Review.

13.

The Anatomy of Caprine Female Urethra and Characteristics of Muscle and Bone Marrow Derived Caprine Cells for Autologous Cell Therapy Testing.

Burdzinska A, Dybowski B, Zarychta-Wisniewska W, Kulesza A, Zagozdzon R, Gajewski Z, Paczek L.

Anat Rec (Hoboken). 2017 Mar;300(3):577-588. doi: 10.1002/ar.23498. Epub 2016 Nov 25.

14.

Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma.

Trzeciecka A, Klossowski S, Bajor M, Zagozdzon R, Gaj P, Muchowicz A, Malinowska A, Czerwoniec A, Barankiewicz J, Domagala A, Chlebowska J, Prochorec-Sobieszek M, Winiarska M, Ostaszewski R, Gwizdalska I, Golab J, Nowis D, Firczuk M.

Oncotarget. 2016 Jan 12;7(2):1717-31. doi: 10.18632/oncotarget.6435.

15.

Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.

Siernicka M, Winiarska M, Bajor M, Firczuk M, Muchowicz A, Bobrowicz M, Fauriat C, Golab J, Olive D, Zagozdzon R.

Immunology. 2015 Sep;146(1):173-83. doi: 10.1111/imm.12494. Epub 2015 Jul 8.

16.

Cancer stem cells in haematological malignancies.

Zagozdzon R, Golab J.

Contemp Oncol (Pozn). 2015;19(1A):A1-6. doi: 10.5114/wo.2014.47127. Review.

17.

Statins impair glucose uptake in human cells.

Nowis D, Malenda A, Furs K, Oleszczak B, Sadowski R, Chlebowska J, Firczuk M, Bujnicki JM, Staruch AD, Zagozdzon R, Glodkowska-Mrowka E, Szablewski L, Golab J.

BMJ Open Diabetes Res Care. 2014 Apr 26;2(1):e000017. doi: 10.1136/bmjdrc-2014-000017. eCollection 2014.

18.

Dynamics of acute local inflammatory response after autologous transplantation of muscle-derived cells into the skeletal muscle.

Burdzinska A, Gala K, Kowalewski C, Zagozdzon R, Gajewski Z, Pączek L.

Mediators Inflamm. 2014;2014:482352. doi: 10.1155/2014/482352. Epub 2014 Aug 27.

19.

In silico analysis of microRNA-510 as a potential oncomir in human breast cancer.

Gaj P, Zagozdzon R.

Breast Cancer Res. 2014;16(2):403. No abstract available.

20.

Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.

O'Leary PC, Terrile M, Bajor M, Gaj P, Hennessy BT, Mills GB, Zagozdzon A, O'Connor DP, Brennan DJ, Connor K, Li J, Gonzalez-Angulo AM, Sun HD, Pu JX, Pontén F, Uhlén M, Jirström K, Nowis DA, Crown JP, Zagozdzon R, Gallagher WM.

Breast Cancer Res. 2014 Jul 10;16(4):R79. doi: 10.1186/bcr3691.

Supplemental Content

Loading ...
Support Center